Monte Rosa Therapeutics, Inc. - Common Stock (GLUE)
Seasonality Analysis
Monte Rosa Therapeutics, Inc. - Common Stock Annual Seasonality Statistics
Monte Rosa Therapeutics, Inc. - Common Stock Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January | -4.48% | Very Weak | |
| February | -2.08% | Weak | |
| March | 3.09% | Moderate | |
| April WORST | -15.97% | Weak | |
| May | -9.93% | Very Weak | |
| June | 5.17% | Moderate | |
| July | 6.33% | Very Strong | |
| August | 11.78% | Moderate | |
| September | -4.68% | Very Weak | |
| October BEST | 29.09% | Very Strong | |
| November | 3.15% | Weak | |
| December | 10.25% | Weak |
Monte Rosa Therapeutics, Inc. - Common Stock 2026 vs Historical Pattern
Monte Rosa Therapeutics, Inc. - Common Stock Interactive Seasonality Chart
Monte Rosa Therapeutics, Inc. - Common Stock Pattern Scanner
Monte Rosa Therapeutics, Inc. - Common Stock Seasonal Historical Performance
About Monte Rosa Therapeutics, Inc. - Common Stock (GLUE) Seasonality
Monte Rosa Therapeutics, Inc. - Common Stock (GLUE) has been analyzed using 5 years of historical data to identify seasonal patterns. Classified under Stocks, Monte Rosa Therapeutics, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.
The strongest month for Monte Rosa Therapeutics, Inc. - Common Stock is historically October, with an average return of 29.09% and a win rate of 80%. Conversely, April tends to be the weakest month, averaging -15.97% return.
Looking at the full calendar year, Monte Rosa Therapeutics, Inc. - Common Stock has an average annual return of 31.73% with an overall monthly win rate of 47.1%. Out of 12 months, 7 typically show positive average returns.
The seasonal pattern for Monte Rosa Therapeutics, Inc. - Common Stock has a consistency score of 45 (Poor), based on 6 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
Monte Rosa Therapeutics, Inc. - Common Stock Seasonality FAQ
What is the best month to buy Monte Rosa Therapeutics, Inc. - Common Stock (GLUE)?
Historically, October has been the best month for Monte Rosa Therapeutics, Inc. - Common Stock, with an average return of 29.09% and a win rate of 80%. However, past performance does not guarantee future results.
What is the worst month for Monte Rosa Therapeutics, Inc. - Common Stock (GLUE)?
Based on historical data, April has been the weakest month for Monte Rosa Therapeutics, Inc. - Common Stock, with an average return of -15.97%. This is a historical observation and does not guarantee future results.
How reliable is GLUE seasonality data?
The seasonality analysis for Monte Rosa Therapeutics, Inc. - Common Stock is based on 5 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use Monte Rosa Therapeutics, Inc. - Common Stock seasonality in my trading?
Use Monte Rosa Therapeutics, Inc. - Common Stock (GLUE) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.